[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@argenxglobal "#NEWS: The ADAPT SERON study in AChR-Ab seronegative gMG met its primary endpoint. We plan to submit an sBLA to the FDA by the end of 2025. This milestone reflects our long-term commitment to the MG community and advancing understanding of disease biology. #TogetherWeDiscover"
X Link @argenxglobal 2025-08-25T11:06Z 1159 followers, XXX engagements

"At @AANEMorg and @MyastheniaOrg Scientific Session we will present clinical trial and real-world data demonstrating our ongoing commitment to neuromuscular disease innovation. #AANEMinSanFran #TogetherWeDiscover"
X Link @argenxglobal 2025-10-15T15:49Z 1159 followers, XXX engagements